Wednesday, July 8, 2026

pharma · Urinary Tract Infections · Respiratory Tract Infection Viral · ITRMF

Iterum Therapeutics

Iterum Therapeutics is a pharma organization headquartered in Dublin, IE. It trades on NYSE under ticker ITRMF. Primary therapeutic focus areas include Urinary Tract Infections, Respiratory Tract Infection Viral, UTI - L

Dublin, IE HQ
2015 Founded
19 Employees
Public company Type
ITRMF · NYSE Ticker
Company details
Status
Public
HQ
Dublin, IE
Founded
2015
Employees
19
Programs
8
Drugs
8
Patents
3
Clinical program

Ertapenem

Phase 3 · small molecule · Intra Abdominal Infections

Ertapenem for Intra Abdominal Infections is a Phase 3 program (small_molecule) at Iterum Therapeutics plc with 1 ClinicalTrials.gov record(s).

← All Iterum Therapeutics plc projects Phase 3 small molecule completed

Internal code IT001-303

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Iterum Therapeutics plc
Phase
Phase 3
Modality
small_molecule
Indication
Intra Abdominal Infections
Status
completed
Trials
1